Bär, A.; Schmitt-Grohé, S.; Held, J.; Lubig, J.; Hanslik, G.; Fahlbusch, F.B.; Reutter, H.; Woelfle, J.; van der Donk, A.; Schleier, M.;
et al. Evaluating the Use of Neonatal Colonization Screening for Empiric Antibiotic Therapy of Sepsis and Pneumonia. Antibiotics 2023, 12, 189.
https://doi.org/10.3390/antibiotics12020189
AMA Style
Bär A, Schmitt-Grohé S, Held J, Lubig J, Hanslik G, Fahlbusch FB, Reutter H, Woelfle J, van der Donk A, Schleier M,
et al. Evaluating the Use of Neonatal Colonization Screening for Empiric Antibiotic Therapy of Sepsis and Pneumonia. Antibiotics. 2023; 12(2):189.
https://doi.org/10.3390/antibiotics12020189
Chicago/Turabian Style
Bär, Alisa, Sabina Schmitt-Grohé, Jürgen Held, Julia Lubig, Gregor Hanslik, Fabian B. Fahlbusch, Heiko Reutter, Joachim Woelfle, Adriana van der Donk, Maria Schleier,
and et al. 2023. "Evaluating the Use of Neonatal Colonization Screening for Empiric Antibiotic Therapy of Sepsis and Pneumonia" Antibiotics 12, no. 2: 189.
https://doi.org/10.3390/antibiotics12020189
APA Style
Bär, A., Schmitt-Grohé, S., Held, J., Lubig, J., Hanslik, G., Fahlbusch, F. B., Reutter, H., Woelfle, J., van der Donk, A., Schleier, M., Hepp, T., & Morhart, P.
(2023). Evaluating the Use of Neonatal Colonization Screening for Empiric Antibiotic Therapy of Sepsis and Pneumonia. Antibiotics, 12(2), 189.
https://doi.org/10.3390/antibiotics12020189